WallStSmart
AXGN

Axogen Inc

NASDAQ: AXGN · HEALTHCARE · MEDICAL DEVICES

$43.20
+3.42% today

Updated 2026-04-30

Market cap
$2.22B
P/E ratio
P/S ratio
9.33x
EPS (TTM)
$-0.64
Dividend yield
52W range
$9 – $46
Volume
1.1M

Axogen Inc (AXGN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+63.6%
Last 4 quarters
Revenue YoY growth
+21.3%
Most recent quarter
EPS YoY growth
+0.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+10.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+25.4%
2025-10-29
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-03$0.07+19.5%$30.65$29.22-4.7%
2025-10-29$0.12+71.4%$18.08$22.68+25.4%
2025-08-05$0.12+100.0%$12.55$13.75+9.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.06$0.07+19.5%$59.90M+21.3%
2025-09-30$0.07$0.12+71.4%$60.08M+23.5%
2025-06-30$0.06$0.12+100.0%$56.66M+18.3%
2025-03-31$0.02$-0.02-225.0%$48.56M+17.4%
2024-12-31$0.03$0.07+133.3%$49.41M+15.1%
2024-09-30$0.01$0.07+600.0%$48.64M+17.9%
2024-06-30$-0.04$0.05+225.0%$47.91M+25.6%
2024-03-31$-0.07$-0.06+14.3%$41.38M+12.9%
2023-12-31$-0.10$-0.06+40.0%$42.92M
2023-09-30$-0.06$0.01+116.7%$41.27M
2023-06-30$-0.13$-0.03+76.9%$38.16M
2023-03-31$-0.14$-0.10+28.6%$36.66M

Frequently asked questions

Has Axogen Inc beaten earnings estimates?
Axogen Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +63.6% over the last 3 quarters.
How does AXGN stock react to earnings?
AXGN stock has moved an average of +10.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Axogen Inc's revenue growth rate?
Axogen Inc reported year-over-year revenue growth of +21.3% in its most recent quarter, with EPS growing +0.0% year-over-year.